Success Metrics

Active Trials
2(40%)

Phase Distribution

Ph phase_3
3
60%
Ph phase_4
1
20%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Other(3)

Detailed Status

unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 33 (60.0%)
Phase 41 (20.0%)

Trials by Status

unknown360%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_3

Acetyl-leucine in Post-stroke Ataxia

NCT07275749
recruitingphase_3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

NCT06360120
unknownphase_3

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

NCT05718531
unknownphase_2

Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia

NCT05233124
unknownphase_4

DUAL Antithrombotic Therapy in Patients With AF and ACS

NCT04023630

Clinical Trials (5)

Showing 5 of 5 trials
NCT07275749Phase 3

Acetyl-leucine in Post-stroke Ataxia

Recruiting
NCT06360120Phase 3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Recruiting
NCT05718531Phase 3

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

Unknown
NCT05233124Phase 2

Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia

Unknown
NCT04023630Phase 4

DUAL Antithrombotic Therapy in Patients With AF and ACS

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5